Pluristem Therapeutics Inc (PSTI)

[TC43]

I am not an expert but I have two guesses on this debate.

1) All the literature says that they are determining the dosage on large animals. After that,it says there will be another "pivotal trial" that will lead to fast commercial marketization. Maybe the final trial is a fast track that evaluates safety?

OR

2) If they are treating ARS, the safety concerns may take a back seat to the fact that a population will have a high death rate either way. Safety wouldn't matter if a person is probably dead anyway. I'd guess there is an exemption based on compassionate use.